Cointime update: Pfizer will halt sales of its Premarin hormone therapy in Canada, the company confirmed. The decision removes a long-established menopausal hormone treatment from the Canadian market. Pfizer did not give a reason or a timeline for the withdrawal in the statement.
Pfizer to stop selling Premarin hormone therapy in Canada
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
3h ago
House Democrats Target Trump Inner Circle in First Oversight Requests
3h ago
US Democrats Plan Data Center Power Reform, Operators May Pay $35B More Over 10 Years
3h ago
Democrats to Probe Trump’s $100B Venezuela Oil Deal
5h ago
UBS Global Wealth Management Forecasts S&P 500 at 8,200 by End-2027
5h ago
Tencent Q3 2026 Revenue Rises 8% to RMB 207.3 Billion
5h ago
Onshore yuan closes at 6.6653 per dollar, up 2 pips